Mark L Pacala Sells $200K of Oncology Institute Inc (TOI) — SEC Form 4, Nov 20, 2025

Open-Market Net Sale · SEC Form 4
−$200,000

Equity position changed by -22.2%

Reporting Owner
Mark L Pacala
Director
TXN 2025-11-18 · FILED 2025-11-20
Equity Position 175K sh 224,971 → 174,971
Equity Change -22.2% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

Oncology Institute Inc

TOI CIK 0001799191
All Oncology Institute Inc insider activity
Filing Date
2025-11-20
Report Date
2025-11-18
Accession No.
0001079973-25-001813
Accepted At
2025-11-20 21:55 UTC
Reporting Owner
Name Relationship
Mark L Pacala CIK 0001321250
Director
Mark L Pacala at Oncology Institute Inc Full insider history
Bought (12 mo) —
Sold (12 mo) $200,000
More from this insider at Oncology Institute Inc
2026-07-29 Award — View
2025-11-24 Award — View
2025-03-28 Buy +$99,834 View
2024-11-25 Award — View
2024-11-18 Gift/Other — View
All filings by this insider at Oncology Institute Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2025-11-18 S - Sale 2,160 D $4.00 -$8,640 222,811 Direct
Common StockF1 2025-11-18 S - Sale 1,210 D $4.00 -$4,840 221,601 Direct
Common StockF1 2025-11-18 S - Sale 46,630 D $4.00 -$186,520 174,971 Direct
Footnotes (1)
F1
Represents sale of Common Stock acquired from previously vested RSU awards. Show more

Related filings at Oncology Institute Inc

Institutional Holders
13F holders · Jun 30, 2026 119 institutional managers reporting a position
Largest by reported value
  1. Black Rock, Inc. $25.8M
  2. Deerfield Management Company, L.P. (Series C) $18.2M
  3. Vanguard Capital Management Llc $17.7M
5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Oncology Institute Inc
All Oncology Institute Inc insider activity
GET /v1/forms/4/0001079973-25-001813 API docs
View Original SEC Filing